Shyon
04-22

Personally, I am long-term bullish for $UnitedHealth(UNH)$ but for short to mid term, it is not as interesting as compared to AI stocks. It suits investors with a lot of patience and who love steady return. 

UnitedHealth is an American multinational health insurance and services company. Selling insurance products under UnitedHealthcare, and health care services and care delivery aided by technology and data under Optum, it is the world's eleventh-largest company by revenue and the largest health care company by revenue.

A key reason UnitedHealth Group could get to a $1 trillion market cap is the company's relentless pursuit of growth. UnitedHealth's broad business involves not just health insurance, but analytics as well. And the company hasn't been afraid to get bigger and diversify via acquisitions.

In the fourth quarter, the company's medical loss ratio increased to 85%, higher than analysts expected. Medical loss ratio, or the percentage of premiums the company pays out to cover claims, is a key indicator of profitability for a company like UnitedHealth. The higher the medical loss ratio, the less room the company has to make a profit.

Hope this analysis helps.

@TigerPicks  @Tiger_comments  @MillionaireTiger  @TigerStars  @CaptainTiger  @Daily_Discussion  @TigerGPT  

@TigerPicks：Will $UNH's Q1 Earnings Serve as the Catalyst for Stock Rebound?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • TigerGPT
    04-22
    TigerGPT

    UnitedHealth Group (UNH) Stock Analysis

    Business Overview: UnitedHealth Group is an American multinational health insurance and services company. It sells insurance products under UnitedHealthcare and provides health care services and care delivery aided by technology and data under Optum. It is the world's eleventh-largest company by revenue and the largest health care company by revenue.

      

    Earnings Analysis: The latest earnings report for UnitedHealth Group shows that in Q1 2024, the company reported an EPS of -1.53 USD, with a gross profit margin of 23.05%. The return on investment was 11.77%, and the net profit margin was -1.41%. These figures indicate some challenges in the recent quarter.

      

    Looking at the earnings forecast, analysts predict that UnitedHealth Group's EPS will be 27.60 USD for FY2024, 31.07 USD for FY2025, and 35.03 USD for FY2026. The forecasted gross income is 397.86B USD for FY2024, 427.24B USD for FY2025, and 456.78B USD for FY2026. The forecasted EBIT is 36.67B USD for FY2024, 39.38B USD for FY2025, and 42.52B USD for FY2026.

      Trend Analysis: The current stock price of UnitedHealth Group is 494.43 USD (as of 2024-04-22). The support price on 2024-04-19 was 487.98 USD, and the resistance price was 501.18 USD. The average cost on 2024-04-19 was 485.79 USD. The profiteer ratio on 2024-04-19 was 0.7841.

        

      Valuation Analysis: Analysts have provided target price estimates for UnitedHealth Group. The mean target price is 569.32 USD, with a low estimate of 460.00 USD and a high estimate of 675.00 USD. Additionally, 9 analysts recommend buying the stock, 16 analysts rate it as a buy, and 3 analysts suggest holding the stock.

        

      Capital Flow Analysis: The capital flow data for UnitedHealth Group shows that there has been a mix of inflows and outflows in the past five days. On 2024-04-15, there was an inflow of 20,117.49K units, followed by an inflow of 100,459.4K units on 2024-04-16. On 2024-04-17, there was an inflow of 54,231.31K units, and on 2024-04-18, there was an inflow of 41,425.49K units. On 2024-04-19, there was a significant inflow of 119,887.03K units.

        

      Disclaimer: The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and stock prices can fluctuate. It is essential to conduct thorough research and analysis before making any investment decisions.

    • TigerGPTReplyShyon: 

      As an AI financial analyst, I can provide you with some insights to consider when deciding whether to hold UnitedHealth Group (UNH) for the long term. Please note that this information is for reference purposes only and should not be considered as investment advice. It is always recommended to conduct thorough research and analysis or consult with a financial advisor before making any investment decisions.

      UnitedHealth Group is one of the largest healthcare companies in the United States, offering a wide range of health insurance and healthcare services. Here are some factors to consider when evaluating the long-term potential of UnitedHealth:

      Strong Financial Performance: UnitedHealth has consistently delivered strong financial performance over the years, with steady revenue growth and solid profitability. The company's diversified business segments and strong market position contribute to its stability and growth potential.

        

      Favorable Industry Trends: The healthcare industry is expected to experience long-term growth due to factors such as an aging population, increasing healthcare spending, and advancements in medical technology. UnitedHealth is well-positioned to benefit from these trends as a leading player in the industry.

        

      Robust Business Model: UnitedHealth operates through various business segments, including UnitedHealthcare (health insurance), Optum (health services), and OptumRx (pharmacy benefits management). This diversified business model provides the company with multiple revenue streams and helps mitigate risks.

        

      Innovation and Technology: UnitedHealth has been investing in innovative technologies and digital solutions to improve healthcare delivery and enhance customer experience. These initiatives can contribute to the company's long-term growth and competitiveness.

        

      Regulatory Environment: The healthcare industry is subject to regulatory changes and reforms, which can impact companies operating in the sector. It is important to stay updated on any regulatory developments that may affect UnitedHealth's business operations.

        

      Competitive Landscape: UnitedHealth faces competition from other healthcare companies, both in the insurance and healthcare services sectors. Monitoring the competitive landscape and assessing UnitedHealth's ability to maintain its market position is crucial.

        

      It is important to note that investing in stocks carries risks, and the performance of any individual stock can be influenced by various factors, including market conditions, economic trends, and company-specific events. Therefore, it is advisable to diversify your investment portfolio and consider your risk tolerance and investment goals before making any investment decisions.

      Disclaimer: The information provided here is for informational purposes only and should not be considered as investment advice. The decision to invest in UnitedHealth or any other stock should be based on your own research and analysis.

    • ShyonReplyTigerGPT: 
      Can we hold UnitedHealth for long-term?
    • TigerGPTReplyShyon: 

      UnitedHealth Group (UNH) Valuation Analysis

      Long-term Valuation:

      Analysts have provided target price estimates for UnitedHealth Group. The mean target price is 569.32 USD, with a low estimate of 460.00 USD and a high estimate of 675.00 USD. Additionally, 9 analysts recommend buying the stock, 16 analysts rate it as a buy, and 3 analysts suggest holding the stock.

      Short-term Valuation:

      The current stock price of UnitedHealth Group is 491.23 USD (as of 2024-04-23). The support price on 2024-04-19 was 487.98 USD, and the resistance price was 501.18 USD. The average cost on 2024-04-19 was 485.79 USD. The profiteer ratio on 2024-04-19 was 0.7841.

      Capital Flow Analysis:

      In the past five days, there has been a mix of inflows and outflows for UnitedHealth Group. On 2024-04-15, there was an inflow of 20,117.49K units, followed by an inflow of 100,459.4K units on 2024-04-16. On 2024-04-17, there was an inflow of 54,231.31K units, and on 2024-04-18, there was an inflow of 41,425.49K units. On 2024-04-19, there was a significant inflow of 119,887.03K units.

      Conclusion:

      Based on the target price estimates provided by analysts, UnitedHealth Group's valuation appears positive in the long term. However, short-term valuation can be influenced by stock trends, capital flow, and recent news sentiment. Investors should conduct thorough research and analysis before making any investment decisions.

      Disclaimer:

      The above analysis is for informational purposes only and should not be considered as investment advice. Investing in stocks involves risks, and stock prices can fluctuate. It is essential to conduct thorough research and analysis before making any investment decisions.

    • Shyon: 
      How is UnitedHealth valuation right now?
Leave a comment
5
55